Diverse role of OX40 on T cells as a therapeutic target for skin diseases

H Iriki, H Takahashi, M Amagai - Journal of Investigative Dermatology, 2023 - Elsevier
OX40 is an important costimulatory molecule for T-cell expansion and survival. Because
OX40 is expressed on most T-cell subsets, it is an attractive therapeutic target for a variety of …

Meeting report–Alpine desmosome disease meeting 2024: advances and emerging topics in desmosomes and related diseases

J Waschke, M Amagai, C Becker… - Journal of Cell …, 2025 - journals.biologists.com
Desmosomes are adhesive cell contacts abundant in tissues exposed to mechanical strain,
such as the stratified and simple epithelia of the epidermis and mucous membranes, as well …

Human OX40L–CAR-Tregs target activated antigen-presenting cells and control T cell alloreactivity

X Rui, F Alvarez Calderon, H Wobma… - Science Translational …, 2024 - science.org
Regulatory T cells (Tregs) make major contributions to immune homeostasis. Because Treg
dysfunction can lead to both allo-and autoimmunity, there is interest in correcting these …

Cross-talk between ILC2 and Gata3high Tregs locally constrains adaptive type 2 immunity

J Stockis, T Yip, J Moreno-Vicente, O Burton… - Science …, 2024 - science.org
Regulatory T cells (Tregs) control adaptive immunity and restrain type 2 inflammation in
allergic disease. Interleukin-33 promotes the expansion of tissue-resident Tregs and group 2 …

Immune modulation using extracellular vesicles encapsulated with MicroRNAs as novel drug delivery systems

Y Matsuzaka, R Yashiro - International Journal of Molecular Sciences, 2022 - mdpi.com
Self-tolerance involves protection from self-reactive B and T cells via negative selection
during differentiation, programmed cell death, and inhibition of regulatory T cells. The …

In or out of control: Modulating regulatory T cell homeostasis and function with immune checkpoint pathways

M Abdeladhim, JL Karnell, SA Rieder - Frontiers in Immunology, 2022 - frontiersin.org
Regulatory T cells (Tregs) are the master regulators of immunity and they have been
implicated in different disease states such as infection, autoimmunity and cancer. Since their …

T cell autoimmunity and immune regulation to desmoglein 3, a pemphigus autoantigen

H Takahashi, H Iriki, Y Asahina - The Journal of Dermatology, 2023 - Wiley Online Library
Pemphigus is a life‐threatening autoimmune bullous disease mediated by anti‐desmoglein
IgG autoantibodies. Pemphigus is mainly classified into three subtypes: pemphigus vulgaris …

Emerging strategies for treating autoimmune disease with genetically modified dendritic cells

Y Ma, R Shi, F Li, H Chang - Cell Communication and Signaling, 2024 - Springer
Gene editing of living cells has become a crucial tool in medical research, enabling
scientists to address fundamental biological questions and develop novel strategies for …

Immunostimulatory effects of Toll‐like receptor ligands as adjuvants in establishing a novel mouse model for pemphigus vulgaris

C Gao, M Liu, Y Xin, Y Zeng, H Yang… - Clinical and …, 2024 - Wiley Online Library
Background The meticulous selection of appropriate vaccine adjuvants is crucial for
optimizing immune responses. Traditionally, pemphigus vulgaris (PV), an autoimmune …

Understanding CD4+ T cells in autoimmune bullous diseases

AY Lee, T Kim, JH Kim - Frontiers in Immunology, 2023 - frontiersin.org
Autoimmune bullous diseases (AIBDs) are a group of life-threatening blistering diseases
caused by autoantibodies that target proteins in the skin and mucosa. Autoantibodies are …